Safety and Effectiveness of CATHTONG™ II PICC

NACompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

October 17, 2018

Primary Completion Date

September 20, 2019

Study Completion Date

October 30, 2020

Conditions
Cancer
Interventions
DEVICE

PICC with high pressure tolerance

Subjects signed informed consent, meet the inclusion criteria and did not meet the exclusion criteria, and were randomly admitted to the experimental group and given the intervention.

DEVICE

rontine central venous catheter

Subjects signed informed consent, meet the inclusion criteria and did not meet the exclusion criteria, and were randomly admitted to the control group and given the intervention.

Trial Locations (4)

310000

Sir Run Run Shaw Hospital, Hangzhou

Zhejiang Provincial Tongde Hospital, Hangzhou

310009

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

Unknown

Affiliated Cancer Hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT03841955 - Safety and Effectiveness of CATHTONG™ II PICC | Biotech Hunter | Biotech Hunter